A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist, Naltrexone, in the Treatment of Kleptomania
@article{Grant2009ADP, title={A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist, Naltrexone, in the Treatment of Kleptomania}, author={J. Grant and S. Kim and B. Odlaug}, journal={Biological Psychiatry}, year={2009}, volume={65}, pages={600-606} }
BACKGROUND
Kleptomania is a rare psychiatric disorder characterized by recurrent stealing and for which there exists no empirically validated treatments. This study examined the efficacy and tolerability of the opioid antagonist naltrexone in adults with kleptomania who have urges to steal.
METHODS
An 8-week, double-blind, placebo-controlled trial was conducted to evaluate the safety and efficacy of oral naltrexone for kleptomania. Twenty-five individuals with DSM-IV kleptomania were… CONTINUE READING
Supplemental Clinical Trials
Interventional Clinical Trial
The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in
kleptomania.
Conditions | Kleptomania |
---|---|
Intervention | Drug |
Topics from this paper
Paper Mentions
77 Citations
A Double-Blind, Placebo-Controlled Trial of Lamotrigine for Pathological Skin Picking: Treatment Efficacy and Neurocognitive Predictors of Response
- Psychology, Medicine
- Journal of clinical psychopharmacology
- 2010
- 53
- PDF
Exposure and response prevention therapy augmented with naltrexone in kleptomania: a controlled case study using galvanic skin response for monitoring.
- Medicine
- Behavioural and cognitive psychotherapy
- 2019
- 2
Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis
- Medicine
- BMC Medicine
- 2019
- 13
- PDF
The use of naltrexone in pathological and problem gambling: A UK case series
- Psychology, Medicine
- Journal of behavioral addictions
- 2018
- 3
Naltrexone in the Treatment of Broadly Defined Behavioral Addictions: A Review and Meta-Analysis of Randomized Controlled Trials
- Medicine
- European Addiction Research
- 2017
- 16
Opioid antagonists in broadly defined behavioral addictions: a narrative review
- Medicine
- Expert opinion on pharmacotherapy
- 2016
- 19
A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.
- Medicine
- Drug and alcohol dependence
- 2018
- 14
References
SHOWING 1-10 OF 37 REFERENCES
A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
- Psychology, Medicine
- The Journal of clinical psychiatry
- 2008
- 161
An open-label study of naltrexone in the treatment of kleptomania.
- Psychology, Medicine
- The Journal of clinical psychiatry
- 2002
- 84
Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
- Psychology, Medicine
- The American journal of psychiatry
- 1999
- 310
A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.
- Medicine
- Archives of general psychiatry
- 1999
- 266
- PDF
Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation.
- Psychology, Medicine
- The Journal of clinical psychiatry
- 2007
- 31
Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling
- Psychology, Medicine
- Biological Psychiatry
- 2001
- 382
Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials.
- Medicine
- The international journal of neuropsychopharmacology
- 2005
- 182
- PDF
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
- Psychology, Medicine
- The American journal of psychiatry
- 2006
- 254